RHHBY - Roche Holding AG

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in CHF. All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue55,746,00052,636,00050,403,00049,866,000
Cost of Revenue15,889,00015,079,00014,246,00012,978,000
Gross Profit39,857,00037,557,00036,157,00036,888,000
Operating Expenses
Research Development10,529,00010,050,0009,455,0008,980,000
Selling General and Administrative11,367,00010,343,00010,940,00010,844,000
Non Recurring----
Others311,000316,000305,000554,000
Total Operating Expenses38,096,00035,788,00034,946,00033,356,000
Operating Income or Loss17,650,00016,848,00015,457,00016,510,000
Income from Continuing Operations
Total Other Income/Expenses Net-5,402,000-3,841,000-3,470,000-3,995,000
Earnings Before Interest and Taxes17,650,00016,848,00015,457,00016,510,000
Interest Expense-598,000-707,000-885,000-946,000
Income Before Tax12,248,00013,007,00011,987,00012,515,000
Income Tax Expense3,423,0003,274,0002,931,0002,980,000
Minority Interest2,566,0002,491,0002,321,0001,972,000
Net Income From Continuing Ops8,825,0009,733,0009,056,0009,535,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income8,633,0009,576,0008,863,0009,332,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares8,633,0009,576,0008,863,0009,332,000